VeraForm can be adapted to the demands of the patient’s anatomy.  A simple pattern can be created using as much or as little material as needed, leaving a highly identifiable 3-D mark.

VeraForm can be adapted to the demands of the patient’s anatomy.  A simple pattern can be created using as much or as little material as needed, leaving a highly identifiable 3-D mark.  


September 29, 2022 — Radformation Inc and Videra Surgical are pleased to announce a collaboration integrating Videra Surgical’s VeraForm tumor bed marker and Radformation’s AI-driven AutoContour Software.
Following a lumpectomy, surgical clips are commonly placed to identify the residual tumor bed to aid post-surgical radiation therapy, often delivered weeks after surgery. However, due to conventional imaging and variability often present with surgical clips, identifying and contouring the tumor bed can sometimes be imprecise during treatment planning. 

The VeraForm radiopaque, continuous, three-dimensional multi-planar tissue marker can be identified on conventional planning CT images to delineate the tumor bed precisely. When used in conjunction with AutoContour, users are provided with a variety of contouring tools and automated workflows to quickly detect and contour VeraForm. AutoContour generates AI-driven contours for organs at risk, nodal regions in the head, thorax, and pelvis, and automates multiple boolean operations to generate planning volumes to deliver the exact targeting necessary for accurate and effective radiation therapy.
"Videra is committed to forming best-in-class collaborations to further our Women's Health Initiative’s to optimize the standard of care for patients and accelerate the workflow for often time-consuming steps that may impede patient treatment," said Joe Guido, Chief Executive Officer of Videra Surgical. "AutoContour allows VeraForm users to create consistent high-quality contours, and we look forward to applying that standardization to advance the clinical applications of VeraForm. “
“Our collaboration with Videra represents an exciting advancement in localization, visualization and contouring of the treatment bed that could help patients and their physicians achieve positive radiation therapy outcomes. “ said Joe Ianni, Chief Revenue Officer at Radformation. “We anticipate applying Radformation’s automated workflow to additional disease sites as the use of the Videra marker expands .”
VeraForm and AutoContour will be showcased during the 2022 American Society for Radiation Therapy (ASTRO) Annual Meeting in San Antonio, TX, from October 23rd to the 25th. Attendees are invited to visit Radformation at booth 3001 and Videra at booth 2798 for more information and a demonstration of the integration in action. 

For more information: www.viderasurgical.com 

Find more ASTRO22 coverage here 


Related Content

News | RSNA | By Christine Book

November 27, 2022 — Among dozens of technical exhibit visits, informative discussions, and captivating Plenary Session ...

Time November 27, 2022
arrow
Videos | ASTRO

Dr. Frank A. Vicini, MD, FACR, FASTRO, FABS, who is a radiation oncologist with GenesisCare, discussed his findings from ...

Time November 09, 2022
arrow
News | Radiation Therapy

November 8, 2022 — Elekta announced that Elekta Esprit, a new Leksell Gamma Knife radiosurgery platform, received FDA ...

Time November 08, 2022
arrow
News | Artificial Intelligence

Nov. 4, 2022 — Guerbet announced an agreement with Merative formalizing the termination of their collaboration initiated ...

Time November 05, 2022
arrow
News | Artificial Intelligence

Nov. 4, 2022 — The U.S. Food and Drug Administration (FDA) is recommending health care providers discuss alternative ...

Time November 05, 2022
arrow
News | Proton Therapy

November 3, 2022 — Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation ...

Time November 03, 2022
arrow
Feature | Lung Imaging | By Christine Book

The pace of new lung cancer screening initiatives, published research and collective efforts of organizations and ...

Time November 03, 2022
arrow
News | Radiation Therapy

November 2, 2022 — ViewRay, Inc. announced the launch of a phase III randomized controlled trial titled "Locally ...

Time November 02, 2022
arrow
Feature | ASTRO | Christine Book

November 2, 2022 — The Imaging Technology News (ITN) editorial team is pleased to present the second portion of the ...

Time November 02, 2022
arrow
Subscribe Now